Skip to main content
. 2017 Sep 20;38(5):2825–2835. doi: 10.3892/or.2017.5977

Figure 5.

Figure 5.

Telmisartan increases the level of phospho-p53 (ser392) and decreases the level of survivin. (A) Template showing the location of apoptosis-related proteins on the human apoptosis antibody array. (B) Representative expression levels of various apoptosis-related proteins in HLF cells treated with or without telmisartan. (C) The densitometric ratio of the telmisartan-treated group to the non-treated group for the phospho-p53 (ser392) and survivin spots (*P<0.05).